Evidence map›Paper›PMID 29572725›Full record

ReviewApplied health economics and health policy2018

Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies.

Margit Sommersguter-Reichmann, Claudia Wild, Adolf Stepan, Gerhard Reichmann, Andrea Fried

Abstract readReview
In one paragraph

Review in Applied health economics and health policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Does voluntary health insurance improve health and longevity? Evidence from European OECD countries.The European journal of health economics : HEPAC : health economics in prevention and care · 2022
    Article
  7. Editorial: Fraud and Corruption in Healthcare.Frontiers in public health · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Insights From Organized Crime for Disorganized Health Care.The Journal of ambulatory care management
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Margit Sommersguter-ReichmannDepartment of Finance, Karl-Franzens University of Graz, Graz, Austria. margit.sommersguter@uni-graz.at.ORCID 0000-0002-0501-8416
Claudia WildLudwig Boltzmann Institute of Health Technology Assessment, Vienna, Austria.
Adolf StepanInstitute of Management Science, Technical University Vienna, Vienna, Austria.
Gerhard ReichmannDepartment of Information Science and Information Systems, Karl-Franzens University of Graz, Graz, Austria.
Andrea FriedTransparency International-Austrian Chapter, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the fight against healthcare corruption has intensified. Estimates from the European Healthcare Fraud and Corruption Network calculate an approximate €56 billion annual loss to Europe as a result of corruption. To promote understanding of the complexity and interconnection of corrupt activities, we aim to present healthcare-related corruption typologies of the European Union and European Healthcare Fraud and Corruption Network. We subsequently link them to the typology of individual and institutional corruption introduced by Dennis Thompson in the context of investigating misconduct of US Congressional members. According to Thompson, individual corruption is the personal gain of individuals performing duties within an institution in exchange for nurturing private interests, while institutional corruption pertains to the failure of the institution in directing the individual's behaviour towards the achievement of the institution's primary purpose because the institutional design promotes the pursuit of individual goals. Effective anti-corruption activities not only require the enactment of anti-corruption laws but also the monitoring and, where appropriate, revision of institutional frameworks to prevent the undermining of the primary purposes of health systems or institutions. To gain further understanding of the similarities and differences of the three typologies, prime examples of corrupt activities in the health sector in the European Union and USA (along with their potential remedies) are provided. Linking corruption cases to Thompson's typology revealed that many corrupt activities may show elements of both individual and institutional corruption because they are intertwined, partly overlap and may occur jointly. Hence, sanctioning individual actors only does not target the problem.

Indexed as

Drug SubstitutionHealth PolicyBiosimilar PharmaceuticalsEuropeGastrointestinal AgentsHumansInflammatory Bowel DiseasesInfliximabInsurance, Health, ReimbursementRandomized Controlled Trials as TopicBiosimilar PharmaceuticalsGastrointestinal AgentsInfliximab

Identifiers

PMID29572725
PMCPMC5940713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.